Delivery Order SPE2DB20D2104-SPE2DB25FMNVK
Award Date
4/17/25
Potential Completion Date
4/18/25
Potential Value
$7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $7,188.72 and an ultimate completion date of February 20, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Candesartan Cilexetil 16 mg tablets in 90-count bottles, with a ceiling value of $4,854.63 and a period of performance through March 12, 2025. The contract does not have a set-aside designation, indicating open competition. This delivery order is part of a larger Indefinite...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $7,897.46, is for the delivery of 4,567,137,152 units of Candesartan Cilexetil 16 mg tablets in 90-count bottles. The contract has an ultimate completion date of February 4, 2025 and utilizes a firm fixed-price pricing structure. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued...
This is a $31,487.62 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,824,771 units of Candesartan Cilexetil 16 mg tablets. The contract has a completion date of January 3, 2025 and was awarded on January 2, 2025. This delivery order is part of a larger $999,999,999 indefinite delivery contract (IDC) that Amerisourcebergen...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Candesartan Cilexetil 16 mg tablets, a prescription medication. The contract has a ceiling value of $39,839.69 and an ultimate completion date of September 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a firm fixed price, a ceiling value of $4,120.47, and a period of performance through May 16, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Candesartan Cilexetil 16 mg tablets, a medication used to treat high blood pressure and heart failure. The contract has a ceiling value of $1,787.82 and a completion date of April 22, 2025. This contract is not set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Candesartan Cilexetil 32 mg tablets in 90-count packages, with a ceiling value of $6,296.40 and an ultimate completion date of January 8, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Candesartan Cilexetil 16 mg tablets, a cardiovascular medication, with a ceiling value of $4,744.06 and a completion date of November 15, 2024. The contract is a firm-fixed-price type and does not have any set-aside designations, indicating it was open competition. AmerisourceBergen holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $25,848.46, is for the supply of Candesartan Cilexetil 16 mg tablets. The award has an ultimate completion date of August 30, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical for delivering a wide range of...